基因编辑革命地图
CRISPR Decoded
探索正在塑造基因医学未来的技术、疗法、疾病、科学家、公司、临床试验与重大发现。
15 treatments tracked
14 clinical trials
教育参考资料·仅供研究·不构成任何医疗建议
You are in Guided View. Terms are explained as you go, and every page opens with a plain-language
summary before the technical detail. Switch back to Expert View from the menu at any time.
从你实际所在的位置出发
本网站同时面向截然不同的读者群体。以下每个入口从不同角度进入同一数据库。内容不做简化处理,也不预设读者具备生物学学位。
探索基因编辑
科学家改变遗传物质的七种方式。每个页面以通俗易懂的语言开篇,再按你的意愿深入探索。
CRISPR-Cas9A protein that can be programmed with a short RNA guide to find one specific sequence in a genome and cut it.
Hiroshi Nishimasu, F. Ann Ran,... · CC BY-SA 3.0
Base EditingChemically converts one DNA letter into another at a chosen position, without cutting both strands of the double helix.
Prime EditingWrites a new stretch of DNA sequence directly into a chosen site, using a guide that carries the replacement text with it.
CRISPR-Cas12A family of CRISPR nucleases that cut DNA leaving staggered ends, use a different sequence requirement from Cas9, and can be smaller.
CRISPR-Cas13Targets RNA rather than DNA, so it can silence a gene's message without touching the genome itself.
Cas14 and miniature Cas systemsUnusually small CRISPR nucleases, roughly a third the size of Cas9, discovered in archaea and bacteriophages.
RNA EditingChanges letters in the RNA message rather than in the DNA, so the effect is real but temporary and the genome is untouched.
并排对比精准性、切割方式、载荷大小、递送方式、成熟度、风险
正在攻克的疾病
每个疾病页面都会直接说明基因编辑目前是已获批的治疗方案、正在临床试验中,还是仍处于实验室研究阶段。
Sickle Cell DiseaseBlood disorders
SpicyMilkBoy · CC BY-SA 4.0
Beta ThalassemiaBlood disorders
Dr Graham Beards · CC BY-SA 4.0
ATTR AmyloidosisMetabolic disease
Hereditary AngioedemaRare genetic disease
LucyHAE · CC BY-SA 3.0
High Cholesterol and Familial HypercholesterolemiaCardiovascular disease
CancerCancer
Mikael Häggström, M.D. Author info... · CC0
Leukemia and LymphomaCancer
https://wellcomeimages.org/indexplu... · CC BY 4.0
HIVInfectious disease
Photo Credit: C. Goldsmith
Content... · Public domain
Duchenne Muscular DystrophyMuscular disease
Dr. Edwin P. Ewing, Jr. · Public domain
Cystic FibrosisRare genetic disease
治疗方法
收录已命名的药物,每条记录均注明监管状态。
Casgevy (exagamglogene autotemcel)The first CRISPR-based medicine approved anywhere in the world: a one-time therapy made from a patient's own edited blood stem cells.
Lyfgenia (lovotibeglogene autotemcel)Approved on the same day as Casgevy for sickle cell disease, but a gene-addition therapy, not gene editing, which makes the pair a useful comparison.
Zynteglo (betibeglogene autotemcel)An approved gene-addition therapy for transfusion-dependent beta thalassemia: the non-editing alternative to Casgevy in the same disease.
Nexiguran ziclumeran (nex-z)The first CRISPR therapy ever administered into a human bloodstream: a single infusion intended to switch off the TTR gene in the liver for good.
Lonvoguran ziclumeran (lonvo-z)The first in vivo gene-editing therapy to report a positive Phase 3 result: a single infusion intended to stop hereditary angioedema attacks permanently.
Risto-cel (BEAM-101)A base-editing therapy for sickle cell disease that mimics a naturally protective genetic variant, with a licence application signalled for as early as the end of 2026.
CRISPR Decoded 中的已批准药物: Casgevy (exagamglogene autotemcel) · Lyfgenia (lovotibeglogene autotemcel) · Zynteglo (betibeglogene autotemcel)
临床试验
证据究竟是在哪里产生的。
4招募中
2进行中,不再招募
7已完成
CLIMB SCD-121: the trial that led to the first CRISPR medicine approvalSickle cell disease · NCT03745287
CLIMB THAL-111: the beta thalassemia trial behind the Casgevy approvalBeta thalassemia · NCT03655678
MAGNITUDE: Phase 3 in vivo CRISPR for ATTR cardiomyopathyATTR amyloidosis · NCT06128629
MAGNITUDE-2: Phase 3 in vivo CRISPR for ATTR polyneuropathyATTR amyloidosis · NCT06672237
HAELO: the first positive Phase 3 result for in vivo gene editingHereditary angioedema · NCT06634420
BEACON: base editing for sickle cell diseaseSickle cell disease · NCT05456880
值得关注的企业
谁在研发什么,以及每个项目的进展程度。
CRISPR TherapeuticsCRSP · Zug, Switzerland
Intellia TherapeuticsNTLA · Cambridge, Massachusetts
Beam TherapeuticsBEAM · Cambridge, Massachusetts
Editas MedicineEDIT · Cambridge, Massachusetts
Prime MedicinePRME · Cambridge, Massachusetts
Verve Therapeutics私有 · Boston, Massachusetts
Caribou BiosciencesCRBU · Berkeley, California
Sana BiotechnologySANA · Seattle, Washington
改变领域的科学家
每位贡献者的实际贡献——这一领域的署名权存在争议,我们会注明分歧所在。
Jennifer DoudnaStructural biochemist who, with Emmanuelle Charpentier, showed that Cas9 could be programmed with a single guide RNA to cut chosen DNA, and shared the 2020 Nobel Prize in Chemistry for it.
Christopher Michel · CC BY-SA 4.0
Emmanuelle CharpentierMicrobiologist who discovered tracrRNA, the missing component of the CRISPR-Cas9 system, and shared the 2020 Nobel Prize in Chemistry with Jennifer Doudna.
Bianca Fioretti, Hallbauer & Fioretti · CC BY-SA 4.0
Feng ZhangBioengineer who led one of the first demonstrations of CRISPR genome editing in human cells and discovered several new CRISPR systems including Cas12a and Cas13.
PuppyEggs · CC BY-SA 4.0
David LiuChemical biologist whose laboratory invented base editing and prime editing, the two techniques that changed gene editing from cutting to writing.
ServiceAT · CC BY-SA 4.0
George ChurchGeneticist whose laboratory independently demonstrated CRISPR editing in human cells in 2013, and a founder of an unusually large number of genomics companies.
Christopher Michel · CC BY-SA 4.0
Virginijus ŠikšnysLithuanian biochemist who independently showed that Cas9 could be programmed to cut DNA, publishing in 2012, and whose contribution is often omitted from popular accounts.
Gie2016 · CC BY-SA 4.0
基因编辑最新动态
来自知名出版方的真实文章。每条标题均链接至原文——我们从不改写或转载。
Backed by Amish and Mennonites, a new kind of gene therapy company takes shape
LANCASTER, PA — This spring, Lorraine and Mark Martin, a Mennonite family with a tax business, adopted a stubby-legged cow named Royal Lite. Lorraine…
Rice plants can fight off devastating disease after gene editing with AI-designed tool
University of Missouri researchers have created rice plants that resist bacterial blight, a devastating disease that threatens one of the world's most…
STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
Bonjour Genomics: A Video from ASHG
GEN editors Uduak Thomas and Julianna LeMieux, PhD, recap ASHG, highlighting key sessions, Ultima Genomics’ user group meeting, Illumina news, and…
Artiva to wind down after two patient deaths in autoimmune cell therapy trials
Cell therapy biotech Artiva Biotherapeutics abruptly announced Tuesday morning that it is effectively shutting down and laying off almost all of its staff…
Outpace ends an ovarian cancer trial; Incyte data impresses at ESMO
Plus news about Genmab, Rumi, Prana and Fractyl. Outpace Bio ends cell therapy trial: The Seattle startup canned a Phase 1 ovarian cancer trial of its…
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is…
Spatial Proteomics for Precision Oncology
In this GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples. The post Spatial…
Rice plants can fight off devastating disease after gene editing with AI-designed tool
University of Missouri researchers have created rice plants that resist bacterial blight, a devastating disease that threatens one of the world's most…
STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
Bonjour Genomics: A Video from ASHG
GEN editors Uduak Thomas and Julianna LeMieux, PhD, recap ASHG, highlighting key sessions, Ultima Genomics’ user group meeting, Illumina news, and…
Artiva to wind down after two patient deaths in autoimmune cell therapy trials
Cell therapy biotech Artiva Biotherapeutics abruptly announced Tuesday morning that it is effectively shutting down and laying off almost all of its staff…
Outpace ends an ovarian cancer trial; Incyte data impresses at ESMO
Plus news about Genmab, Rumi, Prana and Fractyl. Outpace Bio ends cell therapy trial: The Seattle startup canned a Phase 1 ovarian cancer trial of its…
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is…
Spatial Proteomics for Precision Oncology
In this GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples. The post Spatial…
CRISPR 解析
从最基础的地方开始,无需任何生物学背景。
What is DNA?DNA is a long chemical chain that stores the instructions for building and running a living…
What is a gene?A gene is a stretch of DNA that carries the instructions for making one particular thing the…
What is a chromosome?A chromosome is one very long DNA molecule packaged with proteins; humans normally have 46, in…
What is a genome?A genome is the complete set of genetic instructions in an organism: every chromosome, every…
What is RNA?RNA is DNA's working copy: a temporary, single-stranded version the cell makes when it needs to…
What is a mutation?A mutation is a change in DNA sequence. Most do nothing, some cause disease, and a few are…
在继续阅读之前
CRISPR Decoded 是一个教育性参考资源,不提供医疗建议。有关实验性疗法的信息,并不能证明该疗法安全或有效。临床试验及监管状态会频繁变化。如果您需要就自身或家人的健康做出决策,请咨询具备资质的医疗专业人员。
阅读完整免责声明 →